17h
HealthDay on MSNASA: Alteplase Ups Outcomes at 4.5 to 24 Hours After Symptom Onset in Acute Ischemic StrokeFor patients with acute ischemic stroke (AIS) whose symptoms began 4.5 to 24 hours earlier, alteplase is associated w ...
The challenges of translating neuroprotective interventions with promising efficacy in animal studies into effective treatments for patients with stroke are well documented, with issues including ...
A University of Alabama at Birmingham Heersink School of Medicine-led study suggests that first-time transient ischemic ...
The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, ...
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.
The following is a summary of “Hyponatremia is associated with malignant brain edema after mechanical thrombectomy in acute ...
(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first ...
Johnson & Johnson MedTech (NYSE: JNJ) announced today that it launched the CereGlide 92 catheter system for treating acute ...
Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.
Men have a higher risk of IS due to heatwaves and a faster response to their onset, while response in women is delayed.
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results